Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,777 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Long term efficacy of first-line afatinib and the clinical utility of ctDNA monitoring in patients with suspected or confirmed EGFR mutant non-small cell lung cancer who were unsuitable for chemotherapy.
Popat S, Januszewski A, O'Brien M, Ahmad T, Lewanski C, Dernedde U, Jankowska P, Mulatero C, Shah R, Hicks J, Geldart T, Cominos M, Gray G, Spicer J, Bell K, Roitt S, Morris C, Ngai Y, Hughes L, Hackshaw A, Wilson W. Popat S, et al. Among authors: ahmad t. Br J Cancer. 2024 Dec 5. doi: 10.1038/s41416-024-02901-6. Online ahead of print. Br J Cancer. 2024. PMID: 39639088
Treatment of recurrent or metastatic renal cell carcinoma.
Shah RN, Ahmad T, Eisen TG. Shah RN, et al. Among authors: ahmad t. Expert Rev Anticancer Ther. 2004 Dec;4(6):1069-80. doi: 10.1586/14737140.4.6.1069. Expert Rev Anticancer Ther. 2004. PMID: 15606334 Review.
Hydroxychloroquine in combination with platinum doublet chemotherapy as first-line treatment for extensive-stage small cell lung cancer (Study 15): A randomised phase II multicentre trial.
Lee SM, Hewish M, Ahmed S, Papadatos-Pastos D, Karapanagiotou E, Blackhall F, Ford A, Young R, Garcia A, Arora A, Hollingdale A, Ahmad T, Forster M, Greystoke A, Bremner F, Rudd R, Farrelly L, Vaja S, Hackshaw A. Lee SM, et al. Among authors: ahmad t. Eur J Cancer. 2025 Jan 17;215:115162. doi: 10.1016/j.ejca.2024.115162. Epub 2024 Dec 6. Eur J Cancer. 2025. PMID: 39693892 Free article. Clinical Trial.
Sorafenib in advanced melanoma: a Phase II randomised discontinuation trial analysis.
Eisen T, Ahmad T, Flaherty KT, Gore M, Kaye S, Marais R, Gibbens I, Hackett S, James M, Schuchter LM, Nathanson KL, Xia C, Simantov R, Schwartz B, Poulin-Costello M, O'Dwyer PJ, Ratain MJ. Eisen T, et al. Among authors: ahmad t. Br J Cancer. 2006 Sep 4;95(5):581-6. doi: 10.1038/sj.bjc.6603291. Epub 2006 Aug 1. Br J Cancer. 2006. PMID: 16880785 Free PMC article. Clinical Trial.
Sorafenib and dacarbazine as first-line therapy for advanced melanoma: phase I and open-label phase II studies.
Eisen T, Marais R, Affolter A, Lorigan P, Robert C, Corrie P, Ottensmeier C, Chevreau C, Chao D, Nathan PD, Jouary T, Harries M, Negrier S, Montegriffo E, Ahmad T, Gibbens I, James MG, Strauss UP, Prendergast S, Gore ME. Eisen T, et al. Among authors: ahmad t. Br J Cancer. 2011 Jul 26;105(3):353-9. doi: 10.1038/bjc.2011.257. Epub 2011 Jul 12. Br J Cancer. 2011. PMID: 21750549 Free PMC article. Clinical Trial.
1,777 results